The DNA-binding factor TFE3 is closely related to microphthalmia-associated transcription factor (MiTF) and is over-expressed in alveolar soft part sarcoma (ASPS) and select renal cell carcinomas. Reports of TFE3 expression in PEComa prompted investigation into TFE3 expression among other members of the putative MiTF group of neoplasms. The authors examined cases of PEComa (n = 6), conventional angiomyolipoma (AML; n = 22), metastatic melanoma (n = 16), and clear cell sarcoma (CCS; n = 9) for TFE3 expression. Nuclear immunostaining was observed in 74% (39/53) of cases, as follows: 5/6 PEComas, 18/22 AMLs, 10/16 metastatic melanomas, and 6/9 CCSs. However, with the exception of PEComas, compared with ASPS controls, TFE3 staining was significantly less intense in the tumors examined. These results illustrate that TFE3 immunoreactivity is detectable in other members of the MiTF family of neoplasms. For this reason, such neoplasms warrant consideration in the differential diagnosis with nuclear TFE3 immunoreactivity, particularly when staining is focal and less intense.
King R., Weilbaecher KN, McGill G., Cooley E., Mihm M., Fisher DEMicrophthalmia transcription factor: a sensitive and specific melanocyte marker for melanoma diagnosis. Am J Pathol. 1999;155:731-738.
2.
Granter SR, Weilbaecher KN, Quigley C., Fletcher CD, Fisher DEClear cell sarcoma shows immunoreactivity for microphthalmia transcription factor: further evidence for melanocytic differentiation. Mod Pathol. 2001;14:6-9.
3.
Zavala-Pompa A., Folpe AL, Jimenez RE, et al. Immunohistochemical study of microphthalmia transcription factor and tyrosinase in angiomyolipoma of the kidney, renal cell carcinoma, and renal and retroperitoneal sarcomas: comparative evaluation with traditional diagnostic markers. Am J Surg Pathol. 2001;25:65-70.
4.
Folpe AL, Goodman ZD, Ishak KG, et al. Clear cell myomelanocytic tumor of the falciform ligament/ligamentum teres: a novel member of the perivascular epithelioid clear cell family of tumors with a predilection for children and young adults. Am J Surg Pathol. 2000;24:1239-1246.
5.
Folpe AL, Mentzel T., Lehr HA, Fisher C., Balzer BL, Weiss SWPerivascular epithelioid cell neoplasms of soft tissue and gynecologic origin: a clinicopathologic study of 26 cases and review of the literature. Am J Surg Pathol. 2005;29:1558-1575.
6.
Henthorn PS, Stewart CC, Kadesch T., Puck JMThe gene encoding human TFE3, a transcription factor that binds the immunoglobulin heavy-chain enhancer, maps to Xp11.22. Genomics. 1991;11:374-378.
7.
Steingrimsson E., Copeland NG, Jenkins NAMelanocytes and the microphthalmia transcription factor network. Annu Rev Genet. 2004;38:365-411.
8.
Ladanyi M., Lui MY, Antonescu CR, et al. The der(17) t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25. Oncogene. 2001;20:48-57.
9.
Argani P., Lal P., Hutchinson B., Lui MY, Reuter VE, Ladanyi M.Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assay. Am J Surg Pathol. 2003;27: 750-761.
10.
Argani P., Antonescu CR, Illei PB, et al. Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents. Am J Pathol. 2001;159:179-192.
11.
Argani P., Olgac S., Tickoo SK, et al. Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrum. Am J Surg Pathol . 2007;31:1149-1160.
12.
Argani P., Aulmann S., Karanjawala Z., Fraser RB, Ladanyi M., Rodriguez MMMelanotic Xp11 translocation renal cancers: a distinctive neoplasm with overlapping features of pecoma, carcinoma, and melanoma. Am J Surg Pathol . 2009;33:609-619.
13.
Antonescu CR, Dal Cin P., Nafa K., Teot LA, Surti U., Fletcher CD, et al. EWSR1-CREB1 is the predominant gene fusion in angiomatoid fibrous histiocytoma. Genes Chromosomes Cancer. 2007 ;46:1051-1060.
14.
Righi A., Dimosthenous K., Rosai J.PEComa: another member of the MiT tumor family? Int J Surg Pathol. 2008;16:16-20.
15.
Cho HY, Chung DH, Khurana H., Zhai QJ, Ro JYThe role of TFE3 in PEComa. Histopathology. 2008;53:236-249.
16.
Harvey JM, Clark GM, Osborne CK, Allred DCEstrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer . J Clin Oncol. 1999;17: 1474-1481.
17.
Bonetti F., Pea M., Martignoni G., Zamboni G.PEC and sugar. Am J Surg Pathol. 1992;16:307-308.
18.
Martignoni G., Pea M., Reghellin D., Zamboni G., Bonetti F.PEComas: the past, the present and the future . Virchows Arch. 2008;452:119-132.
19.
Lim SD, Stallcup W., Lefkove B., et al. Expression of the neural stem cell markers NG2 and L1 in human angiomyolipoma: are angiomyolipomas neoplasms of stem cells? Mol Med. 2007;13:160-165.
20.
Francis F., Nonaka D.A study of MITF/TFE transcription factors and melanocytic differentiation markers in angiomyolipomas. Mod Pathol.2009 ; 22:13A-4A.
21.
Davis IJ, Kim JJ, Ozsolak F., et al. Oncogenic MITF dysregulation in clear cell sarcoma: defining the MiT family of human cancers. Cancer Cell. 2006;9:473-484.
22.
Cocker RS, Kahn LB, Mehrotra B., Morgenstern N.A TFE3+ gastrointestinal tumour: report of a case. Histopathology . 2006;48:771-773.
23.
Antonescu CR , Nafa K., Segal NH, Dal Cin P., Ladanyi M.EWS-CREB1: a recurrent variant fusion in clear cell sarcoma: association with gastrointestinal location and absence of melanocytic differentiation. Clin Cancer Res. 2006;12: 5356-5362.
24.
Verastegui C., Bertolotto C., Bille K., Abbe P., Ortonne JP, Ballotti R.TFE3, a transcription factor homologous to microphthalmia, is a potential transcriptional activator of tyrosinase and TyrpI genes. Mol Endocrinol. 2000;14:449-456.
